178 related articles for article (PubMed ID: 22534012)
21. Gd(DOTA): an alternative to Gd(DTPA) as a T1,2 relaxation agent for NMR imaging or spectroscopy.
Magerstädt M; Gansow OA; Brechbiel MW; Colcher D; Baltzer L; Knop RH; Girton ME; Naegele M
Magn Reson Med; 1986 Oct; 3(5):808-12. PubMed ID: 3784897
[TBL] [Abstract][Full Text] [Related]
22. Magnetic-optical dual-modality imaging monitoring chemotherapy efficacy of pancreatic ductal adenocarcinoma with a low-dose fibronectin-targeting Gd-based contrast agent.
Zhang W; Liang X; Zhang X; Tong W; Shi G; Guo H; Jin Z; Tian J; Du Y; Xue H
Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):1841-1855. PubMed ID: 38372766
[TBL] [Abstract][Full Text] [Related]
23. [Study on biodistribution and imaging of radioiodinated antisense oligonucleotides in nude mice bearing human lymphoma].
Shen J; Wang RF; Zhang CL; Liu M; Guo FQ
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 36(6):655-9. PubMed ID: 15605104
[TBL] [Abstract][Full Text] [Related]
24. [A comparison on radiochemical behavior and biological property of antisense oligonucleotide labeled with technetium-99m by two methods: NHS-MAG3 versus SHNHP].
Li Y; Tan T; Zheng J; Zhang C
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):889-93, 902. PubMed ID: 18788302
[TBL] [Abstract][Full Text] [Related]
25. Imaging human pancreatic cancer xenografts by targeting mutant KRAS2 mRNA with [(111)In]DOTA(n)-poly(diamidopropanoyl)(m)-KRAS2 PNA-D(Cys-Ser-Lys-Cys) nanoparticles.
Amirkhanov NV; Zhang K; Aruva MR; Thakur ML; Wickstrom E
Bioconjug Chem; 2010 Apr; 21(4):731-40. PubMed ID: 20232877
[TBL] [Abstract][Full Text] [Related]
26. Tumor Contrast Enhancement and Whole-Body Elimination of the Manganese-Based Magnetic Resonance Imaging Contrast Agent Mn-PyC3A.
Erstad DJ; Ramsay IA; Jordan VC; Sojoodi M; Fuchs BC; Tanabe KK; Caravan P; Gale EM
Invest Radiol; 2019 Nov; 54(11):697-703. PubMed ID: 31356382
[TBL] [Abstract][Full Text] [Related]
27. A low molecular weight folate receptor targeted contrast agent for magnetic resonance tumor imaging.
Kalber TL; Kamaly N; So PW; Pugh JA; Bunch J; McLeod CW; Jorgensen MR; Miller AD; Bell JD
Mol Imaging Biol; 2011 Aug; 13(4):653-62. PubMed ID: 20809208
[TBL] [Abstract][Full Text] [Related]
28. Gadolinium-DOTA enhanced MR imaging of intracranial lesions.
Parizel PM; Degryse HR; Gheuens J; Martin JJ; Van Vyve M; De La Porte C; Selosse P; Van de Heyning P; De Schepper AM
J Comput Assist Tomogr; 1989; 13(3):378-85. PubMed ID: 2723166
[TBL] [Abstract][Full Text] [Related]
29. Polylysine-Gd-DTPAn and polylysine-Gd-DOTAn coupled to anti-CEA F(ab')2 fragments as potential immunocontrast agents. Relaxometry, biodistribution, and magnetic resonance imaging in nude mice grafted with human colorectal carcinoma.
Curtet C; Maton F; Havet T; Slinkin M; Mishra A; Chatal JF; Muller RN
Invest Radiol; 1998 Oct; 33(10):752-61. PubMed ID: 9788138
[TBL] [Abstract][Full Text] [Related]
30. [Inhibitory effect of hTERT dsRNA on telomerase activity in lung carcinoma cell line A549].
Tian FJ; Wang ZY; Ma JY; Zhao YX; Lu W
Ai Zheng; 2005 Mar; 24(3):257-61. PubMed ID: 15757523
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and characterization of a cell-permeable bimodal contrast agent targeting β-galactosidase.
Keliris A; Ziegler T; Mishra R; Pohmann R; Sauer MG; Ugurbil K; Engelmann J
Bioorg Med Chem; 2011 Apr; 19(8):2529-40. PubMed ID: 21459584
[TBL] [Abstract][Full Text] [Related]
32. MR molecular imaging of tumours using ferritin heavy chain reporter gene expression mediated by the hTERT promoter.
Yang Y; Gong MF; Yang H; Zhang S; Wang GX; Su TS; Wen L; Zhang D
Eur Radiol; 2016 Nov; 26(11):4089-4097. PubMed ID: 26960542
[TBL] [Abstract][Full Text] [Related]
33. Targeted therapy of human laryngeal squamous cell carcinoma in vitro by antisense oligonucleotides directed against telomerase reverse transcriptase mRNA.
Tao Z; Chen S; Wu Z; Xiao B; Liu J; Hou W
J Laryngol Otol; 2005 Feb; 119(2):92-6. PubMed ID: 15829059
[TBL] [Abstract][Full Text] [Related]
34. The use of Gd-DOTA in magnetic resonance imaging of experimentally induced mammary tumors.
Bonnet PA; Michel A; Fernandez JP; Cyteval C; Rifai A; Boucard M; Chapat JP; Lamarque JL
Magn Reson Imaging; 1990; 8(1):71-7. PubMed ID: 2325520
[TBL] [Abstract][Full Text] [Related]
35. [Effect of nanosize delivery system for ASODN against hTERT on the expression of telomerase in the esophageal cancer EC9706 cells].
Wang J; Zhang ZZ; Zhou TY; Liu YQ; Li HX
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):566-72. PubMed ID: 19102931
[TBL] [Abstract][Full Text] [Related]
36. Design, Synthesis, and Biological Evaluation of
Liu F; Liu T; Xu X; Guo X; Li N; Xiong C; Li C; Zhu H; Yang Z
Mol Pharm; 2018 Feb; 15(2):619-628. PubMed ID: 29278911
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW
J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394
[TBL] [Abstract][Full Text] [Related]
38. [Preparation and quality control of 99mTc labeled MDR1 oligonucleotide DNAs].
Fan C; Hnatowich DJ
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Jun; 25(3):712-5. PubMed ID: 18693462
[TBL] [Abstract][Full Text] [Related]
39. Visualizing the down-regulation of hTERT mRNA expression using gold-nanoflare probes and verifying the correlation with cancer cell apoptosis.
Sun H; Hong M; Yang Q; Li C; Zhang G; Yue Q; Ma Y; Li X; Li CZ
Analyst; 2019 May; 144(9):2994-3004. PubMed ID: 30892312
[TBL] [Abstract][Full Text] [Related]
40. 68Ga-DOTA-NGR as a novel molecular probe for APN-positive tumor imaging using MicroPET.
Zhang J; Lu X; Wan N; Hua Z; Wang Z; Huang H; Yang M; Wang F
Nucl Med Biol; 2014 Mar; 41(3):268-75. PubMed ID: 24438818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
